论文部分内容阅读
随着分子生物化学的迅速发展,对冠状动脉粥样硬化的研究已发展到载脂蛋白水平。我们对现役飞行人员的脱辅基脂蛋白B(apo-B)和脱辅基脂蛋白AI(apo-AI)进行了检测。现将结果报告如下:
With the rapid development of molecular biochemistry, the research on coronary atherosclerosis has developed to apolipoprotein level. We tested apolipoprotein B (apo-B) and apolipoprotein AI (apo-AI) on active pilots. The results reported below: